Dr. Maria Luisa Calabrò, Biologist

  • Role of the microenvironment in the pathogenesis of virus-induced lymphoma
  • Relevance of epithelial-mesenchymal transition (EMT) in highly aggressive tumors

Prof. Vincenzo Ciminale, MD

  • Harnessing redox homeostasis and cell death pathways for treatment of T-cell leukemia

Dr. Luigi Corti, MD

  • Identification of new biomarkers of radiosensitivity/resistance for patient stratification and personalized radiotherapy treatment planning

Dr. Arcangela De Nicolo, MD, PhD

  • Elucidating genotype-phenotype correlations in hereditary cancer syndromes

Prof. Anita De Rossi, PhD

  • Mechanisms promoting Epstein Barr Virus (EBV)-driven  malignancies
  • New approaches for the diagnosis and monitoring of tumors: telomere/telomerase complex

Dr. Annarosa Del Mistro, MD

  • HPV testing and novel biomarkers in prevention and diagnosis of cervical and oropharyngeal HPV-driven carcinomas

Dr. Stefano Indraccolo, MD

  • Metabolic adaptation of tumors to anti-angiogenic therapy
  • Genetic profiling of lung cancer
  • NOTCH as a therapeutic target in cancer

Dr. Erich Piovan, MD, PhD

  • Targeting de-regulated signalling pathways in T cell acute lymphoblastic leukemia (T-ALL)

Dr. Samantha Serpentini, Psychologist

  • The role of self-efficacy in coping with cancer

Dr. Valeria Tosello, Biologist

  • Molecular pathogenesis of T-cell acute lymphoblastic leukaemia and lymphoma